IDENTIFICATION OF TARGETS FOR TCR-IMMUNOTHERAPY IN HEPATOCELLULAR CARCINOMA USING A CLINICALLY RELEVANT PLATFORM

被引：0
|
作者：
Maravelia, P. [1 ]
Potti, A. Perez [1 ]
Silva, D. Nascimento [1 ]
Healy, K. [1 ]
Sekine, T. [1 ]
Chrobok, M. [1 ]
Jorns, C. [1 ]
Sallberg, M. [1 ]
Buggert, M. [1 ]
Pasetto, A. [1 ]
机构：
[1] Karolinska Inst, Stockholm, Sweden
来源：
CYTOTHERAPY | 2021年 / 23卷 / 05期
关键词：
immunotherapy; hepatocellular carcinoma; T cell receptor;
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
409
引用
收藏
页码：S90 / S90
页数：1
相关论文
共 50 条
  • [31] Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma
    Wang, Wen
    Zhao, Lan Juan
    Tan, Ye Xiong
    Ren, Hao
    Qi, Zhong-Tian
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (38) : 5442 - 5453
  • [32] Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma
    Wen Wang
    World Journal of Gastroenterology, 2012, (38) : 5442 - 5453
  • [33] Machine learning-based identification of telomere-related gene signatures for prognosis and immunotherapy response in hepatocellular carcinoma
    Lu, Zhengmei
    Chai, Xiaowei
    Li, Shibo
    MOLECULAR CYTOGENETICS, 2025, 18 (01)
  • [34] Genome-wide molecular screening for the identification of new targets in human hepatocellular carcinoma
    Longerich, T.
    PATHOLOGE, 2012, 33 : 302 - 306
  • [35] Epigenetic targets in hepatocellular carcinoma cells: identification of chaperone protein complexes with histone deacetylases
    Farooq, Muhammad
    Wadaan, Mohammad A. M.
    EPIGENOMICS, 2013, 5 (05) : 501 - 512
  • [36] Identification of Platform-Independent Diagnostic Biomarker Panel for Hepatocellular Carcinoma Using Large-Scale Transcriptomics Data
    Kaur, Harpreet
    Dhall, Anjali
    Kumar, Rajesh
    Raghava, Gajendra P. S.
    FRONTIERS IN GENETICS, 2020, 10
  • [37] HBV-infected hepatocellular carcinoma can be robustly classified into three clinically relevant subgroups by a novel analytical protocol
    Cheng, Zhiwei
    Li, Leijie
    Zhang, Yuening
    Ren, Yongyong
    Gu, Jianlei
    Wang, Xinbo
    Zhao, Hongyu
    Lu, Hui
    BRIEFINGS IN BIOINFORMATICS, 2023, 24 (02)
  • [38] Identification and validation a costimulatory molecule gene signature to predict the prognosis and immunotherapy response for hepatocellular carcinoma
    Hu, Yinan
    Liu, Jingyi
    Yu, Jiahao
    Yang, Fangfang
    Zhang, Miao
    Liu, Yansheng
    Ma, Shuoyi
    Zhou, Xia
    Wang, Jingbo
    Han, Ying
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [39] Identification of cancer-associated fibroblasts signature for predicting the prognosis and immunotherapy response in hepatocellular carcinoma
    Ye, Jianzhong
    Tian, Wen
    Zheng, Bigeng
    Zeng, Tao
    MEDICINE, 2023, 102 (45) : E35938
  • [40] Identification of ribosomal protein S21 as a potential prognostic and immunotherapy biomarker for hepatocellular carcinoma
    Pan, Junhan
    Zhang, Cong
    Sa, Guo
    Huang, Huizhen
    Zhang, Rui
    Chen, Feng
    ASIAN JOURNAL OF SURGERY, 2025, 48 (01) : 137 - 149
12345